ScholarIQanswers from OpenAlex

Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases”

PaperCitations, authors & open-access status

Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” have?

ScholarIQcitation count

Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” has 0 citations in the OpenAlex counts ScholarIQ stores.

When was Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” published?

ScholarIQyear

Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” has 2026 year in the ScholarIQ index.

What is the open-access status of Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases”?

ScholarIQoa status

Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” has gold oa status in the ScholarIQ index.

What is the DOI of Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases”?

ScholarIQdoi

The DOI for Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” is on the source record.

What is the PMID of Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases”?

ScholarIQpmid

The PMID for Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” is on the source record.

What is the OpenAlex record for Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases”?

ScholarIQopenalex

The OpenAlex for Corrigendum to “New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular Diseases” is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial